A new study published in Blood Purification examined the association between markers of chronic kidney disease mineral and bone disorder CKD MBD and mortality in hemodialysis HD patients. This retrospectively review analyzed the association between markers of CKD MBD and mortality in 1 126 HD patients from 2009 to 2013. The results showed that hypercalcemia 10.9 11.9 mg dL indicated an increased risk of all cause mortality. Likewise hypophosphatemia 2.0 2.5 mg dL was significantly associated with an increased risk of all cause mortality. While hypophosphatemia 2.0 mg dL was also significantly associated with an increased risk of cardiovascular mortality. On the other hand intact parathyroid hormone levels 60 and 1 500 pg mL indicated an increased risk of all cause mortality. From the findings it was concluded that extreme values of CKD MBD markers are associated with mortality risk in HD patients.